Home › Funds › Richard Young Associates, Ltd. › GNLX

Richard Young Associates, Ltd. position in GNLX

GENELUX CORPORATION · Health Care

Richard Young Associates, Ltd. reported holding 40,959 shares of GNLX (GENELUX CORPORATION) in its Q3 2026 13F filing — a position valued at US$104K, representing 0.07% of its reported portfolio and ranking #30 among its reported holdings. Richard Young Associates, Ltd. has disclosed GNLX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)40.96K sh
Reported value held$103.63K
Portfolio Weight0.07%
First reportedQ4 2025
Last changeHold
Updated2026-11-04

Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR

How Richard Young Associates, Ltd.'s GNLX position evolved

Richard Young Associates, Ltd. first disclosed a stake in GNLX in Q4 2025 at 40,959 shares (US$179K). Across 4 filings, Richard Young Associates, Ltd. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 40,959 shares valued at US$104K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 40.96K $178.58K New
Q1 2026 40.96K $99.12K Hold
Q2 2026 40.96K $123.29K Hold
Q3 2026 40.96K $103.63K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GNLX and 13F data

GNLX (GENELUX CORPORATION) is a Health Care company. 30 other funds we track also report a position in GNLX — the largest reported positions include WOODWARD DIVERSIFIED CAPITAL, LLC (US$6.8M), Bleichroeder LP (US$4.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GNLX

All GNLX fund holders →

FAQ

How long has Richard Young Associates, Ltd. held GNLX?

Richard Young Associates, Ltd. has disclosed GNLX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Richard Young Associates, Ltd.'s current position in GNLX?

As of Q3 2026, Richard Young Associates, Ltd. holds 40.96K shares of GNLX (GENELUX CORPORATION), valued at $103.63K, representing 0.07% of its reported portfolio and ranking #30.

Has Richard Young Associates, Ltd. been buying or selling GNLX?

In the latest 13F filing (Q3 2026), Richard Young Associates, Ltd. held unchanged its position in GNLX.

Which other funds hold GNLX?

Other major institutional holders of GNLX include WOODWARD DIVERSIFIED CAPITAL, LLC, Bleichroeder LP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.